Press release
Bacterial Pneumonia Market Size Projected To Reach 3.51 Billion By 2034 With A Cagr Of 8.7%
Bacterial Pneumonia Market Size
What Is the Projected Growth of the Bacterial Pneumonia Market?
The market size for bacterial pneumonia has seen impressive growth in the past few years. It's expected to increase from $2.31 billion in 2024 to $2.52 billion in 2025, following a compound annual growth rate (CAGR) of 9.0%. This upward trend during the historic period can be linked to the increased awareness of respiratory conditions, a rise in recorded bacterial infections, the aging population growth, expanded healare spending, urbanization, and escalating levels of air pollution.
The market size for bacterial pneumonia is anticipated to undergo a robust expansion in the upcoming years, reaching a value of $3.51 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. The projected growth for this period can be traced back to factors such as the rising incidence of alcohol and tobacco usage, escalated governmental efforts and financing, the growing frequency of respiratory infections, increased antibiotic resistance, broader access to healare, improved understanding of bacterial pneumonia, and the escalation in the creation of new therapeutics and vaccines. Key market movements foreseen during this period include the creation of advanced antibiotics, uptake of swift diagnostic tools, progress in vaccine technology, the advent of personalized medicine applications, incorporation of artificial intelligence in illness management, and broadened use of monoclonal antibodies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21109
What Are the Different Bacterial Pneumonia Market Segments?
The bacterial pneumonia market covered in this report is segmented -
1) ?? ????: Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP)
2) By Route Of Administration: Oral, Subcutaneous, Other Route Of Administration
3) By Treatments: Vaccines, Drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Community-Acquired Pneumonia (CAP): Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila
2) By Hospital-Acquired Pneumonia (HAP): Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Enterobacter spp
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21109&type=smp
What Are the Primary Drivers Shaping the Bacterial Pneumonia Market?
The upsurge in the occurrence of respiratory illnesses is anticipated to propel the development of the bacterial pneumonia market in the future. Healare concerns related to breathing and gas exchange interruptions that impact the lungs and airway system organs and tissues are what respiratory diseases signify. Numerous elements, encompassing environmental, lifestyle, demographic, and genetic factors, lead to the upsurge in respiratory diseases' prevalence. These diseases heighten the likelihood of bacterial pneumonia through impairment of the immune system and lung tissue destruction, fostering an atmosphere conducive to bacterial infections. For instance, the Centers for Disease Control and Prevention, which is a US-based government entity, reported in March 2024 that the count of tuberculosis incidents escalated from 8,320 in 2022 to 9,615 in 2023. This represents a surge of 1,295 incidents. Hence, the escalating prevalence of respiratory diseases is stimulating the development of the bacterial pneumonia market.
Which Companies Are Leading in the Bacterial Pneumonia Market?
Major companies operating in the bacterial pneumonia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca PLC, Novartis AG, GSK plc, bioMerieux SA, Shionogi & Co. Ltd., Wockhardt Limited., Zai Lab Limited, Innoviva Inc., Eagle Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc., Clarametyx Biosciences Inc., Evopoint Biosciences Inc., Vaxcyte Inc., Acurx Pharmaceuticals Inc.
What Trends Are Driving Growth in The Bacterial Pneumonia Market?
The bacterial pneumonia market is characterized by leading corporations putting an emphasis on innovative vaccine technology, such as creating conjugate vaccines, to bolster immune response, enhance efficacy and offer extended protection against various bacterial strains. Conjugate vaccines work by connecting a weak antigen to a protein carrier, effectively boosting immunity. An example of this occurred in June 2024 when U.S pharmaceutical firm, Merck & Co. Inc., received approval from the U.S. Food and Drug Administration (FDA) for their Pneumococcal 21-valent Conjugate Vaccine, CAPVAXIVE. The goal of this vaccine is to block the occurrence of invasive pneumococcal disease and pneumonia, caused by varying streptococcus pneumoniae serotypes, mainly focusing on adults aged 18 and above. This product release signifies a noteworthy step in tackling bacterial pneumonia as well as other infections related to pneumococcus.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/bacterial-pneumonia-global-market-report
What Are the Top Revenue-Generating Geographies in the Bacterial Pneumonia Market?
North America was the largest region in the bacterial pneumonia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial pneumonia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Bacterial Pneumonia Market?
2. What is the CAGR expected in the Bacterial Pneumonia Market?
3. What Are the Key Innovations Transforming the Bacterial Pneumonia Industry?
4. Which Region Is Leading the Bacterial Pneumonia Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Pneumonia Market Size Projected To Reach 3.51 Billion By 2034 With A Cagr Of 8.7% here
News-ID: 4069725 • Views: …
More Releases from The Business Research Company
Central Nervous System Lymphoma Treatment Market Size Forecasted To Achieve 1.66 …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Central Nervous System Lymphoma Treatment Market Size and Projected Growth Rate?
There has been robust growth in the market size for central nervous system lymphoma treatment in the past few years. The market which was at $1.19 billion in 2024, is projected to reach $1.28 billion in 2025, seeing…
Roxadustat Market Size Projected To Reach 9.15 Billion By 2034 With A Cagr Of 7. …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Roxadustat Market?
Over the past few years, the Roxadustat market has exhibited robust growth. It is projected to rise from $6.44 billion in 2024 to $6.92 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors such as regulatory green signals in…
Global Resorbable Vascular Scaffolds Market Outlook 2025-2034: Trends, Innovatio …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Resorbable Vascular Scaffolds Market Size and Projected Growth Rate?
The market size of resorbable vascular scaffolds has experienced swift growth in the recent past. It is predicted to increase from $0.46 billion in 2024 to $0.52 billion in 2025, maintaining a compound annual growth rate (CAGR) of 12.9%. The…
Cardiac Tissue Engineering Market Anticipated To Witness Robust Growth, Surpassi …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Cardiac Tissue Engineering Market Size and Its Estimated Growth Rate?
The market size for cardiac tissue engineering has seen a fast-paced expansion in the last few years. It is set to surge from $0.67 billion in 2024 to about $0.81 billion in 2025, marking a compound annual growth…
More Releases for Pneumonia
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth
Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth.
Pneumonia is an…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets.
Report Consultant has introduced a new report titled as Global Pneumonia…
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,…
